These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31132778)

  • 1. Attenuation of Severe Generalized Junctional Epidermolysis Bullosa by Systemic Treatment with Gentamicin.
    Hammersen J; Neuner A; Wild F; Schneider H
    Dermatology; 2019; 235(4):315-322. PubMed ID: 31132778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
    Kwong A; Cogan J; Hou Y; Antaya R; Hao M; Kim G; Lincoln V; Chen Q; Woodley DT; Chen M
    Mol Ther; 2020 May; 28(5):1327-1338. PubMed ID: 32222156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants.
    Mosallaei D; Hao M; Antaya RJ; Levian B; Kwong A; Cogan J; Hamilton C; Schwieger-Briel A; Tan C; Tang X; Woodley DT; Chen M
    JAMA Dermatol; 2022 Apr; 158(4):366-374. PubMed ID: 35234826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin induces
    Lincoln V; Cogan J; Hou Y; Hirsch M; Hao M; Alexeev V; De Luca M; De Rosa L; Bauer JW; Woodley DT; Chen M
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6536-E6545. PubMed ID: 29946029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis Bullosa.
    Hammersen J; Has C; Naumann-Bartsch N; Stachel D; Kiritsi D; Söder S; Tardieu M; Metzler M; Bruckner-Tuderman L; Schneider H
    J Invest Dermatol; 2016 Nov; 136(11):2150-2157. PubMed ID: 27375110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel compound heterozygous mutation in LAMC2 genes (c.79G>A and 382insT) in Herlitz junctional epidermolysis bullosa.
    Jeon IK; Kim SE; Kim SC
    J Dermatol; 2014 Apr; 41(4):322-4. PubMed ID: 24533970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laminin 5 genes and Herlitz junctional epidermolysis bullosa: novel mutations and polymorphisms in the LAMB3 and LAMC2 genes. Mutations in brief no. 190. Online.
    Kon A; Pulkkinen L; Hara M; Tamai K; Tagami H; Hashimoto I; Uitto J
    Hum Mutat; 1998; 12(4):288. PubMed ID: 10660342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa.
    Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D
    J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant splicing as potential modifier of the phenotype of junctional epidermolysis bullosa.
    Mittwollen R; Wohlfart S; Park J; Grosch E; Has C; Hohenester E; Schneider H; Hammersen J
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2127-2134. PubMed ID: 32124492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
    McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
    J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herlitz junctional epidermolysis bullosa.
    Laimer M; Lanschuetzer CM; Diem A; Bauer JW
    Dermatol Clin; 2010 Jan; 28(1):55-60. PubMed ID: 19945616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa.
    Pulkkinen L; Christiano AM; Gerecke D; Wagman DW; Burgeson RE; Pittelkow MR; Uitto J
    Genomics; 1994 Nov; 24(2):357-60. PubMed ID: 7698759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in the LAMB3 gene shared by two Japanese unrelated families with Herlitz junctional epidermolysis bullosa, and their application for prenatal testing.
    Takizawa Y; Shimizu H; Pulkkinen L; Hiraoka Y; McGrath JA; Suzumori K; Aiso S; Uitto J; Nishikawa T
    J Invest Dermatol; 1998 Feb; 110(2):174-8. PubMed ID: 9457915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.
    Yuen WY; Lemmink HH; van Dijk-Bos KK; Sinke RJ; Jonkman MF
    Br J Dermatol; 2011 Dec; 165(6):1314-22. PubMed ID: 21801158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation.
    Sayar SB; Has C
    J Invest Dermatol; 2024 Oct; 144(10):2221-2229.e1. PubMed ID: 38522573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational hotspots in the LAMB3 gene in the lethal (Herlitz) type of junctional epidermolysis bullosa.
    Kivirikko S; McGrath JA; Pulkkinen L; Uitto J; Christiano AM
    Hum Mol Genet; 1996 Feb; 5(2):231-7. PubMed ID: 8824879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel homozygous and compound heterozygous COL17A1 mutations associated with junctional epidermolysis bullosa.
    Floeth M; Fiedorowicz J; Schäcke H; Hammami-Hausli N; Owaribe K; Trüeb RM; Bruckner-Tuderman L
    J Invest Dermatol; 1998 Sep; 111(3):528-33. PubMed ID: 9740252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the LAMB3 hotspot mutation R635X in a Hungarian case of Herlitz junctional epidermolysis bullosa.
    Cserhalmi PB; Horvath A; Boros V; Sapi Z; Kormendi M; Christiano AM; Karpati S
    Exp Dermatol; 1997 Apr; 6(2):70-4. PubMed ID: 9209887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnostics facilitate distinction between lethal and non-lethal subtypes of junctional epidermolysis bullosa: a case report and review of the literature.
    Bauer J; Schumann H; Sönnichsen K; Tomaske M; Bosk A; Bruckner-Tuderman L; Rassner G; Garbe C
    Eur J Pediatr; 2002 Dec; 161(12):672-9. PubMed ID: 12447669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of novel LAMA3 mutation in Herlitz junctional epidermolysis bullosa in a Jordanian family.
    Badran EF; Battah HA; Akl KF; Khalil RW; Al Amori I
    Australas J Dermatol; 2013 Aug; 54(3):218-21. PubMed ID: 22963541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.